When was Kolmar Korea founded?

Kolmar Korea was founded in 1990.

Where is Kolmar Korea located?

Kolmar Korea is headquartered in Seoul, South Korea.

Is Kolmar Korea a funded company?

Kolmar Korea is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Kolmar Korea rank among its competitors?

Kolmar Korea ranks 14th amongst 72 active competitors, of which 2 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Famar, which secured $26.1M in Oct, 2024.

Who are the top competitors of Kolmar Korea?

Kolmar Korea's top competitors include Encube Ethicals, Famar and Crown Laboratories. Among them, Famar secured the most recent funding round in October, 2024.

Kolmar Korea - 2026 Company Profile & Competitors

Company Details

Kolmar Korea, founded as a joint venture with Nihon (Japan) Kolmar, is a CMO specializing in the development and manufacturing of pharmaceuticals and quasi-drugs. The company offers its services right from the stage of formulation development to right until commercial manufacturing. The company also offers analytics, validation, quality assurance, packaging, and distribution services. The company has capabilities for the development and manufacturing of a range of dosage forms such as ointments, external solutions, syrups, solid dosage forms (tablets, capsules), and quasi-drugs. The company had formed joint ventures with pharmaceutical companies such as Kracie (Japan) and Pharmascience (Canada) in 2012.

Website: kolmarpharm.co.kr
Phone Number: +82 **********

Key Metrics

Founded Year

1990

Location

Seoul, South Korea

Stage

Acquired

Ranked

14^th among 72 active competitors

Investment & Acquisitions

Craver & 1 more

Similar Companies

Encube Ethicals & 80 more

Exit Details

Acquired by IMM Private Equity (May 27, 2020)

View Kolmar Korea's full profile

Kolmar Korea got acquired by IMM Private Equity on May 27, 2020.

Click here to take a look at Kolmar Korea's acquisition in detail

Kolmar Korea has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kolmar Korea include Encube Ethicals, Famar and Crown Laboratories. Here is the list of Top 10 competitors of Kolmar Korea, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Encube Ethicals 1998, Mumbai (India), Series D	Company offering contract development and manufacturing services for topical semisolid formulations	$65.5M	Quadria Capital, GII & 3 others	64/100
2nd	Famar 1949, Athens (Greece), Acquired	Contract manufacturing and development services provider	-	Metric Capital, EBRD & 1 others	58/100
3rd	Crown Laboratories 2000, Johnson City (United States), Acquired	Manufacturer of OTC, prescription, skin care and oral care products	-	Greenspring Associates, Montreux Equity Partners ... & 2 others	55/100
4th	Purna 1986, Puurs (Belgium), Acquired	CMO specializing in semi-solid and liquid dosage form manufacturing	-	-	51/100
5th	Curida 2015, Elverum (Norway), Seed	CDMO specialising in liquid pharmaceuticals and blow fill seal technology	$3.2M	Investinor, Sahlgrenska Science Park & 1 others	41/100
6th	Softcaps 2014, Gurugram (India), Unfunded	CDMO focused on manufacturing soft gel pharmaceutical products	-	-	41/100
7th	Lyra Laboratories 2005, Chandigarh (India), Unfunded	Provider of dermatological, dental, and aesthetic condition solutions	-	-	40/100
8th	Disto Pharmaceuticals 2002, Hyderabad (India), Unfunded	Pharmaceuticals company that specializes in developing and manufacturing a range of semi-finished formulations, pellets, and granules	-	-	40/100
9th	Softech Pharma 1962, Daman (India), Unfunded	CDMO focused on manufacturing capsules	-	-	37/100
10th	Chemineau Labs 1947, Vouvray (France), Acquired	CDMO specializing in ENT and topical dosage forms	-	Quilvest, Epiris	35/100
14th	Kolmar Korea 1990, Seoul (South Korea), Acquired	CMO engaged in the manufacturing of pharmaceuticals, cosmetics and functional health foods.	-	-	35/100